Don’t buy the hype.

Feb 23 (Reuters) - Drug developer Generate Biomedicines said on Monday it was targeting a valuation of up to $2.17 billion in its U.S. initial public offering, tapping into a resurgent biotech market ...

Generate Biomedicines Inc., a biotechnology firm using artificial intelligence in drug development, is seeking to raise as much as $425 millon in an initial public offering, as listing activity in the ...

Here is a custom GPT that I quickly made to help answer questions about how to use and integrate Builder.io by simply providing the URL to the Builder docs. This project crawled the docs and generated ...

Microsoft OneNote offers a range of integrations with Outlook, Loop, and Teams, allowing users to streamline workflows and enhance collaboration. As outlined by Mike Tholfsen, these integrations allow ...

Parth is a technology analyst and writer specializing in the comprehensive review and feature exploration of the Android ecosystem. His work is distinguished by its meticulous focus on flagship ...